Key Points
- Alphatec EVP Craig Hunsaker sold 37,358 shares on Feb. 3 at an average price of $14.71 for a total of $549,536.18.
- Following the transaction he still owns 1,173,025 shares, a roughly 3.09% reduction in his stake valued at about $17.26 million.
- Alphatec (ATEC) trades around $14.06 with a market cap of $2.09B and a 52‑week range of $8.81–$23.29; analysts have an average rating of "Moderate Buy" and a consensus target of $22.82.
Alphatec Holdings, Inc. (NASDAQ:ATEC - Get Free Report) EVP Craig Hunsaker sold 37,358 shares of Alphatec stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $14.71, for a total transaction of $549,536.18. Following the sale, the executive vice president owned 1,173,025 shares in the company, valued at approximately $17,255,197.75. This represents a 3.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Alphatec Price Performance
ATEC stock opened at $14.06 on Thursday. The company has a market capitalization of $2.09 billion, a P/E ratio of -13.52 and a beta of 1.01. The company has a fifty day moving average price of $19.22 and a 200-day moving average price of $17.01. The company has a debt-to-equity ratio of 43.02, a quick ratio of 1.24 and a current ratio of 1.99. Alphatec Holdings, Inc. has a 52-week low of $8.81 and a 52-week high of $23.29.
Wall Street Analyst Weigh In
ATEC has been the subject of several analyst reports. TD Cowen restated a "buy" rating on shares of Alphatec in a report on Tuesday, January 27th. Weiss Ratings restated a "sell (e+)" rating on shares of Alphatec in a research report on Monday, December 29th. Canaccord Genuity Group lifted their target price on Alphatec from $20.00 to $25.00 and gave the stock a "buy" rating in a report on Friday, October 31st. Loop Capital set a $25.00 price target on Alphatec in a report on Wednesday, December 10th. Finally, JPMorgan Chase & Co. initiated coverage on shares of Alphatec in a research report on Friday, October 24th. They set an "overweight" rating and a $19.00 price objective for the company. Ten research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $22.82.
Get Our Latest Stock Report on Alphatec
Hedge Funds Weigh In On Alphatec
Large investors have recently added to or reduced their stakes in the business. Aster Capital Management DIFC Ltd purchased a new stake in shares of Alphatec in the third quarter worth approximately $34,000. Osterweis Capital Management Inc. bought a new stake in shares of Alphatec in the 2nd quarter worth $37,000. Nisa Investment Advisors LLC raised its holdings in shares of Alphatec by 22.4% in the second quarter. Nisa Investment Advisors LLC now owns 5,714 shares of the medical technology company's stock valued at $63,000 after purchasing an additional 1,045 shares during the last quarter. China Universal Asset Management Co. Ltd. bought a new position in shares of Alphatec during the third quarter valued at about $73,000. Finally, FNY Investment Advisers LLC purchased a new position in Alphatec during the third quarter worth about $74,000. Institutional investors own 66.35% of the company's stock.
Alphatec Company Profile
(
Get Free Report)
Alphatec Holdings, Inc (NASDAQ: ATEC) is a medical technology company focused on the design, development and commercialization of products for the surgical correction of degenerative spinal conditions. The company's portfolio centers on interbody implants, biologics, fixation devices and surgical planning tools intended to improve patient outcomes in spinal fusion procedures. Alphatec's flagship offerings include customizable interbody cages, bone graft materials and specialized instrumentation designed for minimally invasive and open spinal surgeries.
Founded as Alphatec Spine in 1985 and rebranded as Alphatec Holdings in 2018, the company has grown from a single-product organization into a multi-platform innovator in the spine market.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
